CVS Health Corp (NY:CVS)

90.25 -0.08 (-0.09%)

Official Closing Price Updated: 7:00 PM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2 3 4 5 6 7 8 9

...

72 73 Next >

CVS Health vs. UnitedHealth: Comparing Revenue Trends for These Healthcare Companies ↗

July 05, 2026

UnitedHealth posted a higher net income margin last quarter, while both companies saw their revenue growth pause after a long expansion.

Via The Motley Fool

Vanguard Is Bullish on Value Stocks and Fixed Income. Are These 2 ETFs a Good Buy? ↗

July 05, 2026

Strong productivity gains from AI -- and lower inflation -- could be good news for these Vanguard ETFs.

Via The Motley Fool

Q1 Rundown: Molina Healthcare (NYSE:MOH) Vs Other Health Insurance Providers Stocks

July 02, 2026

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the health insurance providers industry, i...

Via StockStory

Topics Artificial Intelligence Economy Fraud

Q1 Earnings Highs And Lows: UnitedHealth (NYSE:UNH) Vs The Rest Of The Health Insurance Providers Stocks

July 01, 2026

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including UnitedHealth (...

Via StockStory

Topics Artificial Intelligence Economy Fraud

Health Insurance Providers Stocks Q1 Recap: Benchmarking Oscar Health (NYSE:OSCR)

June 29, 2026

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how health insurance provi...

Via StockStory

Topics Artificial Intelligence Economy Fraud

2 Healthcare Stocks with Competitive Advantages and 1 Facing Challenges

June 29, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advanceme...

Via StockStory

CVS Just Turned Its 9,000 Pharmacies Into a GLP-1 Delivery Machine. 1 Top Wall Street Analyst Thinks That's a Reason to Buy the Stock ↗

June 27, 2026

The stock is already up 30% this year.

Via The Motley Fool

Health Insurance Providers Stocks Q1 Results: Benchmarking Humana (NYSE:HUM)

June 24, 2026

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including Humana (NYSE:H...

Via StockStory

Topics Artificial Intelligence Economy Fraud

Winners And Losers Of Q1: Cigna (NYSE:CI) Vs The Rest Of The Health Insurance Providers Stocks

June 23, 2026

Looking back on health insurance providers stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Cigna (NYSE:CI) and its peers....

Via StockStory

Topics Artificial Intelligence Economy Fraud

Why CVS Stock Trounced the Market Today ↗

June 22, 2026

It's expanding its scope of services for GLP-1 obesity medications.

Via The Motley Fool

Explore the top gainers and losers within the S&P500 index in today's session. ↗

June 22, 2026

Via Chartmill

Health Insurance Providers Stocks Q1 Earnings: CVS Health (NYSE:CVS) Best of the Bunch

June 17, 2026

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at CVS Health (NYSE:CVS) and its...

Via StockStory

Topics Artificial Intelligence Economy Fraud

CVS Health's Comeback Is Just Getting Started -- and Its Valuation Still Looks Shockingly Cheap ↗

June 16, 2026

It's not too late to jump on the bandwagon.

Via The Motley Fool

1 Top Wall Street Analyst Thinks CVS Health Could Jump Another 13%. Should You Load Up on the Stock? ↗

June 15, 2026

Don't underestimate the potential upside for this diversified healthcare stock.

Via The Motley Fool

CVS Health (CVS): Buy, Sell, or Hold Post Q1 Earnings?

June 12, 2026

Over the past six months, CVS Health has been a great trade, beating the S&P 500 by 20%. Its stock price has climbed to $100.39, representing a healthy 26.4%...

Via StockStory

Topics Stocks

CVS Health Just Announced Fantastic News to Eli Lilly Stock Investors ↗

June 05, 2026

It's another step in Eli Lilly's quest to cement its lead in the chronic weight management market.

Via The Motley Fool

Q1 Earnings Outperformers: Elevance Health (NYSE:ELV) And The Rest Of The Health Insurance Providers Stocks

June 04, 2026

Let’s dig into the relative performance of Elevance Health (NYSE:ELV) and its peers as we unravel the now-completed Q1 health insurance providers earnings se...

Via StockStory

Topics Artificial Intelligence Economy Fraud

Eli Lilly Wins Back CVS Health, Reverting Novo's Advantage ↗

June 02, 2026

Eli Lilly and Company just secured a big win as it looks to expand GLP-1 access, mending its partnership with top pharmacy benefit manager CVS Health.

Via MarketBeat

The S&P 500 Is Expensive, but These 3 Dividend Stocks Still Look Like Bargains ↗

June 02, 2026

AbbVie, CVS Health, and Verizon Communications are all high-yielding stocks with attractive valuations and robust financials.

Via The Motley Fool

Topics Stocks

3 Dividend Stocks to Buy and Hold Forever ↗

June 02, 2026

These aren't the most exciting businesses, but they have a lot to offer to long-term investors.

Via The Motley Fool

Better Dividend Growth Stock to Buy: CVS Health or UnitedHealth Group? ↗

June 01, 2026

Growth, not yield, is the deciding factor.

Via The Motley Fool

2 Large-Cap Stocks Worth Your Attention and 1 That Underwhelm

May 29, 2026

Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit...

Via StockStory

How Safe Is CVS Health's Dividend? ↗

May 28, 2026

Investors shouldn't lose sleep over the possibility that the dividend is in danger.

Via The Motley Fool

Investment Firm Closes Out Entire $18.1 Million Position in Biotech Stock, According to Latest SEC Filing ↗

May 26, 2026

This biotech focuses on biologic therapies for immunological diseases, with lead candidates in nephrology and infectious disease.

Via The Motley Fool

Topics Regulatory Compliance

3 Overrated Stocks We’re Skeptical Of

May 25, 2026

The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, u...

Via StockStory

Topics Supply Chain

1 S&P 500 Stock with Impressive Fundamentals and 2 We Brush Off

May 22, 2026

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...

Via StockStory

Topics Stocks

1 Mooning Stock Worth Investigating and 2 We Question

May 21, 2026

Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements...

Via StockStory

CVS Health Stock Is Soaring. Could the Rally Just Be Getting Started? ↗

May 20, 2026

CVS is more than a dividend play.

Via The Motley Fool

2 Stocks That Are Much Cheaper Than They Look ↗

May 19, 2026

Looking past stocks because they trade at high trailing earnings multiples can be a costly mistake for investors.

Via The Motley Fool

3 Profitable Stocks with Questionable Fundamentals

May 15, 2026

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...

Via StockStory

Topics Economy Energy

< Previous 1 2 3 4 5 6 7 8 9

...

72 73 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.